Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert Michael Dudley currently holds 180,262 shares of Transcode Therapeutics, Inc. (RNAZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Michael Dudley has been a net buyer of RNAZ stock. They have purchased $281.8K and sold $0 worth of shares.
Robert Michael Dudley's most recent insider trade was on Sep 28, 2023, when they purchased 98,000 shares at $0.51 per share.
Robert Michael Dudley serves as Executive at Transcode Therapeutics, Inc. (RNAZ). They have executed 8 insider transactions totaling $281.8K over their tenure at the company.
Robert Michael Dudley holds the position of Executive at Transcode Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Robert Michael Dudley has shown a buying trading pattern, with $281.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Robert Michael Dudley was on Jun 9, 2023, when they purchased $52.4K worth of RNAZ shares. This transaction involved 19,000 shares at $2.76 per share.
Robert Michael Dudley currently owns 180,262 shares of Transcode Therapeutics, Inc. (RNAZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert Michael Dudley's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert Michael Dudley has 8 Form 4 filings on record as an insider at Transcode Therapeutics, Inc..
Set alerts for Robert Michael Dudley and 40,000+ other insiders.